Is Localized Provoked Vulvodynia Caused by Laxity of the Utero-Sacral Ligaments?

Sponsor
Western Galilee Hospital-Nahariya (Other)
Overall Status
Completed
CT.gov ID
NCT03197337
Collaborator
(none)
17
1
2
7.3
2.3

Study Details

Study Description

Brief Summary

Small-scale experiments conducted by our group have led to the hypothesis that Localized Provoked Vulvodynia (LPV) may be due to laxity of the Utero-Sacral ligaments (USL). According to this hypothesis, the pain experienced by women with LPV is due to the USL's inability to provide appropriate support for the pudendal nerve.

In order to test this hypothesis we will conduct a single-blind randomized control trial in which patients with LPV will undergo a pressure-test - pressure will be temporarily applied to the posterior fornix using a large-sized applicator, thus strengthening the USL and adding support to the pudendal nerve. While the pressure is being applied, the cotton-swab test will be performed (palpating vulvar and vestibular sites using a cotton-swab), and each patient will rate the elicited pain on a scale of 1 to 10 (1 - not painful, 10 - worst pain imaginable).

The results for each patient will be compared to their baseline level of pain (which will be recorded in the beginning of the experiment) and to the level of pain they report while inserting a speculum but not applying any pressure.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pressure-test
N/A

Detailed Description

Patients with LPV who sign an informed consent form will first undergo the cotton-swab test during which they will rate the pain elicited on a scale of 1 to 10. This score will be used as the patient's baseline level of pain for data analysis later. Then, each patient will be randomized into one of two groups: One group which will first undergo the control manipulation and then the study manipulation, or the second group in which the study manipulation will precede the control manipulation. This is done to neutralize a possible effect of the order of the manipulations on the trial's results when the data will be analyzed.

The control manipulation: Inserting a speculum into the vagina without applying pressure.

The study manipulation: First inserting a speculum, then inserting through it a large-sized applicator reaching the posterior fornix, then retrieving the speculum while keeping the applicator in place, and then applying significant pressure to the posterior fornix.

During each of the manipulations, the cotton-swab test will be performed again, and each patient will be asked to rate the level of pain elicited by the test. All data will be recorded, and we will later analyze if there was a significant difference between the pain elicited by the cotton-swab test during the study manipulation compared with the control manipulation, or compared with the baseline test.

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
The participants will not be informed prior to the experiment if they will first undergo the control manipulation or the study manipulation.
Primary Purpose:
Diagnostic
Official Title:
Is Localized Provoked Vulvodynia Caused by Laxity of the Utero-Sacral Ligaments?
Actual Study Start Date :
Jul 23, 2017
Actual Primary Completion Date :
Mar 2, 2018
Actual Study Completion Date :
Mar 2, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Control manipulation first

Patients in this group will first undergo the control manipulation while the study manipulation will follow.

Procedure: Pressure-test
Pressure will be applied to the posterior fornix using a speculum.

Experimental: Study manipulation First

Patients in this group will first undergo the study manipulation while the control manipulation will follow.

Procedure: Pressure-test
Pressure will be applied to the posterior fornix using a speculum.

Outcome Measures

Primary Outcome Measures

  1. Level of pain [Immediate result]

    Patients will rate the level of pain elicited each time the cotton-swab test will be performed, using a 1-10 scale (1 - not painful, 10 - worst pain imaginable).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women who suffer from LPV that are otherwise healthy.

  • Symptoms severity in each patient is either moderate (able to engage in sexual intercourse despite suffering immense pain) or severe (unable to engage in sexual intercourse due to unbearable pain).

  • Patients who have signed an informed consent form.

Exclusion Criteria:
  • Women who suffer from Generalized Vulvodynia.

  • Women who previously received other treatments for LPV, including but not limited to surgery, neuropathic treatment and/or physiotherapy.

  • Women with uterine prolapse.

  • Women who present with genito-urinary infection/inflammation at the day of the trial, or have healed from such a condition less then 14 days prior to the day of the trial.

  • Women who have previously participated in clinical trials under which they received treatment for Vulvodynia.

  • Women with LPV whose symptoms severity is defined as light (able to engage in sexual intercourse while suffering light pain / discomfort).

  • Women who are pregnant at the day of the trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Obstetrics and Gynecology Nahariya Israel

Sponsors and Collaborators

  • Western Galilee Hospital-Nahariya

Investigators

  • Principal Investigator: Jacob Bornstein, Prof, Chair, Obstetrics and Gynecology department

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Prof. Jacob Bornstein, Chairman, Department of Obstetrics & Gynecology, Western Galilee Hospital-Nahariya
ClinicalTrials.gov Identifier:
NCT03197337
Other Study ID Numbers:
  • 004317NHR
First Posted:
Jun 23, 2017
Last Update Posted:
Oct 15, 2019
Last Verified:
Oct 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prof. Jacob Bornstein, Chairman, Department of Obstetrics & Gynecology, Western Galilee Hospital-Nahariya
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 15, 2019